1Carusol A, Licenziatil S, Corullil M, et al. Flow cytometric analysis of activation markers on stimulated T cells and their correlation with cell proliferation[ J]. Cytometry, 1997, 27( 1 ) :71 -76.
2Mougiakakos D, Choudhury A, Lladser A, et al. Regulatory T ceils in cancer[J]. Adv Cancer Res, 2010, 107:57 - 117.
5Kletzmayr J, Kreuzwieser E, Watkins-Riedel T, et al. Long-term oral ganciclovir prophylaxis for prevention of cytomegalovirus infection and disease in cytomegalo-virus high-risk renal transplant recipients [J]. Transplantation, 2000, 70:1174-1180.
6Lowance D, Neumayer HH, Legendre CH, et al. Valacyclovir for the prevention of cytomegalovirus disease after transplantation [J]. N Engl J Med, 1999, 340:1462-1470.
7Prosch S, Kimel V, Dawydowa I, et al. Monitoring of patients for cytomegalovirus after organ transplantation by centrifugation culture and PCR [J]. J Med Virol, 1992, 38(4):246-251.
9Kazatchkine MD, Kaveri SV. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin [J]. N Engl J Med, 2001, 345:747-755.
10Jordan SC, Toyoda M. Treatment of autoimmune diseases and systemic vasculitis with pooled human intravenous immune globulin [J]. Clin Exp Immunol, 1994, 97(suppl 1):31-38.
